Latest News and Press Releases

BERLIN, May 15, 2009 (GLOBE NEWSWIRE) -- Jerini AG (FSE:JI4) reported financial results for the first quarter ended March 31, 2009. Under International Financial Reporting Standards (IFRS), revenues...

BERLIN, May 1, 2009 (GLOBE NEWSWIRE) -- Jerini AG has reached an agreement to sell its wholly owned subsidiary, JPT Peptide Technologies GmbH, to TheraCode GmbH, Mainz, a wholly owned subsidiary of...

BERLIN, April 26, 2009 (GLOBE NEWSWIRE) -- Jerini AG's Supervisory Board approved on Friday, April 24, 2009, the Management Board's decision of April 24, 2009 to wind down the operations of Jerini...

BERLIN, April 26, 2009 (GLOBE NEWSWIRE) -- The Management Board of Jerini AG has today been informed by Shire Deutschland Investments GmbH, an indirect wholly-owned subsidiary of Shire plc (formerly...

BERLIN, Jan. 27, 2009 (GLOBE NEWSWIRE) -- JPT Peptide Technologies GmbH (JPT), a wholly-owned subsidiary of Jerini AG (Frankfurt:JI4), announced today the launch of its new product line: PepTrack(tm)....

BERLIN, Germany, Dec. 16, 2008 (GLOBE NEWSWIRE) -- The Management Board of Jerini AG (FSE:JI4) has received a formal request, according to section 327a of the German Stock Corporation (AktG), from...

BERLIN, Nov. 14, 2008 (GLOBE NEWSWIRE) -- Jerini AG (FSE:JI4) reported financial results according to International Financial Reporting Standards (IFRS) for the first nine months ended September 30,...

BERLIN, Oct. 10, 2008 (GLOBE NEWSWIRE) -- Jerini AG (FSE:JI4) and Shire Deutschland Investments GmbH have completed the strategic review of the assets and programs of Jerini AG, not related to...

* Joint reasoned statement from Management Board and Supervisory Board published * Offer of EUR 6.25 per share determined to be fair * Shire's expertise will ensure Firazyr(r)'s...

BERLIN, Aug. 14, 2008 (PRIME NEWSWIRE) -- Jerini AG (FSE:JI4) reported financial results for the first six months ended June 30, 2008. Under International Financial Reporting Standards (IFRS), total...